Recommendations for Multimodality Cardiac Imaging in Patients with Chagas Disease: A Report from the American Society of Echocardiography in Collaboration With the InterAmerican Association of Echocardiography (ECOSIAC) and the Cardiovascular Imaging Department of the Brazilian Society of Cardiology (DIC-SBC) - 04/01/18
Doi : 10.1016/j.echo.2017.10.019
Harry Acquatella, MD, FASE a : Chair, Federico M. Asch, MD, FASE b : Co-Chair, Marcia M. Barbosa, MD, PhD, FASE c, Marcio Barros, MD, PhD d, Caryn Bern, MD, MPH e, Joao L. Cavalcante, MD, FASE f, Luis Eduardo Echeverria Correa, MD g, Joao Lima, MD h, Rachel Marcus, MD b, Jose Antonio Marin-Neto, MD, PhD i, Ricardo Migliore, MD, PhD j, Jose Milei, MD, PhD k, Carlos A. Morillo, MD l, Maria Carmo Pereira Nunes, MD, PhD m, Marcelo Luiz Campos Vieira, MD, PhD n, Rodolfo Viotti, MD j, ∗
a Centro Medico de Caracas, San Bernardino, Caracas, Venezuela
b Medstar Washington Hospital Center, Washington, District of Columbia
c Socor Hospital, Belo Horizonte, Brazil
d Faculdade de Saúde e Ecologia Humana, Belo Horizonte, Brazil
e University of California, San Francisco, San Francisco, California
f University of Pittsburgh, Pittsburgh, Pennsylvania
g Fundacion Cardiovascular de Colombia, Floridablanca, Colombia
h Johns Hopkins University, Baltimore, Maryland
i Interventional Cardiology Unit, Medical School of Ribeirão Preto, University of São Paulo, São Paulo, Brazil
j Hospital Eva Perón, San Martin, Argentina
k Consejo Nacional de Investigaciones Cientificas y Tecnicas, Buenos Aires, Argentina
l McMaster University, Population Health Research Institute, Hamilton, Ontario, Canada
m Federal University of Minas Gerais, Belo Horizonte, Brazil
n Heart Institute, São Paulo University Medical School, Hospital Israelita Albert Einstein, São Paulo, Brazil
Keywords : Chagas, Cardiomyopathy, Left ventricular aneurysm, Heart failure, Echocardiography, Cardiac magnetic resonance
Abbreviations : 2D, 3D, ASE, ChD, ChHD, CMR, CT, ECG, HF, LA, LGE, LV, LVEF, PW Doppler, RV, RVEF, TEE, TTE
Plan
| The following authors reported relationships with one or more commercial interests: Caryn Bern, MD, MPH, has consulted for Chemogroup. Luis Eduardo Echeverria Correa, MD, has received a research grant from Roche. Joao Lima, MD, has received grant support from Toshiba Medical Systems. Rachel Marcus, MD, is a consultant for Bayer. Carlos A. Morillo, MD, has received grants from the Canadian Institute for Health Research, TDR-WHO (BENEFIT trial), Merck Shape & Dohme (STOP-CHAGAS trial), Bayer, and BMS/Pfizer; has been a speaker for Bayer and Boehringer Ingelheim; and is a member of the advisory board for Boston Scientific. The following authors reported no actual or potential conflicts of interest in relation to this document: Harry Acquatella, MD, FASE, Federico M. Asch, MD, FASE, Marcia M. Barbosa, MD, PhD, FASE, Marcio Barros, MD, PhD, João L. Cavalcante, MD, FASE, Jose Antonio Marin-Neto, MD, PhD, Ricardo Migliore, MD, PhD, Jose Milei, MD, PhD, Maria Carmo Pereira Nunes, MD, PhD, Marcelo Luiz Campos Vieira, MD, PhD, and Rodolfo Viotti, MD. |
|
| Reprint requests: American Society of Echocardiography, 2530 Meridian Parkway, Suite 450 Durham, NC 27713 USA (Email: ase@asecho.org). |
© 2017
American Society of Echocardiography. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 31 - N° 1
P. 3-25 - janvier 2018 Retour au numéro
Article précédent
- JASE 3.0: Entering Our 4th Decade
- Michael H. Picard
- Impact of Significant Mitral Regurgitation on Assessing the Severity of Aortic Stenosis
- Pil Hyung Lee, Jung Ae Hong, Byung Joo Sun, Seungbong Han, Sangwoo Park, Jeong Yoon Jang, Dae-Hee Kim, Duk-Hyun Kang, Jae-Kwan Song, Jong-Min Song
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?